Skip to main content

Rauchen und Krebs

  • Chapter
Book cover Die Onkologie

Zusammenfassung

Mehr als 5,5 Millionen Menschen sterben jährlich weltweit an den Folgen eines bösartigen Tumorleidens. Bis zum Jahr 2020 wird diese Zahl wahrscheinlich auf über 10 Millionen Menschen steigen, wobei den Entwicklungsländern ein Anteil von rund 70% zufällt. Nach Schätzung der Weltgesundheitsorganisation (WHO) ist der Tod als Folge eines bösartigen Tumorleidens bei 40–45% der Männer und 10–15% der Frauen ursächlich auf das chronische lnhalationsrauchen oder den Genuss von Tabakprodukten in anderer Form (Zigarren, Pfeife, Schnupftabak) zurückzuführen.Schätzungen gehen davon aus, dass bei einer weltweiten Reduzierung des Tabakkonsums diese Zahlen in den entwickelten Industrienationen um bis zu 30% sinken würden. Dabei sind mit dem Konsum von Tabakprodukten und der damit verbundenen Exposition gegenüber mehr als 50 sicher als kanzerogen identifizierten Inhaltsstoffen nicht nur bösartige Tumoren assoziiert: Neben chronisch-entzündlichen und destruktiven Lungenerkrankungen (chronische Bronchitis, Emphysem; Müller 1986) sind als direkt tabakkonsumassoziierte Todesursachen vornehmlich kardiovaskuläre Erkrankungen, besonders die koronare Herzkrankheit und der Myokardinfarkt, dokumentiert. Insgesamt wurde die Zahl der Toten 1995 als Folge des Abusus an Tabakprodukten von der WHO weltweit auf rund 1,9 Millionen (1.400.000 Männer; 500.000 Frauen) geschätzt. Andere Schätzungen gehen von jährlich rund 3 Millionen Toten weltweit aus (Boyle 1997).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Adlkofer F, Heller WD (1995) Exposure to environmental tobacco smoke and risk of lung cancer:The epidemiological evidence. Eur Resp J 8: 1240–1241

    Article  CAS  Google Scholar 

  • Bartsch H, Malaveille C, Friesen M, Kadlubar FF, Vineis P (1993) Black (air-cured) and blond (flue-cured) tobacco cancer risk. IV: Molecular dosimetry studies implicate aromatic dimers as bladder carcinogens. EurJ Cancer 29A: 1199–1207

    Article  CAS  Google Scholar 

  • Bennett WP, Colby TV, Travis WD et al. (1993) p53 protein accumulates frequently in early bronchial neoplasia. Cancer Res 53:4817–4822

    PubMed  CAS  Google Scholar 

  • Blum A (1993) Curtailing the tobacco pandemic. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology. Lippincott-Raven, Philadelphia, pp 480–491

    Google Scholar 

  • Blum A (1997) Cancer prevention: preventing tobacco-related cancers. In: DeVita VT, Hellman S, Rosenberg SA (eds.) Cancer: principles and practice of oncology. Lippincott-Raven, Philadelphia, pp 545–55

    Google Scholar 

  • Bouchardy C, Benhamou S, Dayer P (1996) The effect of tobacco on lung cancer risk depends on CYP2D6 activity. Cancer Res 56: 251–253

    PubMed  CAS  Google Scholar 

  • Boyle P (1997) Cancer, cigarette smoking and premature death in Europe: a review including the recommendations of European Cancer Experts Consensus Meeting, Helsinki, October 1996. Lung Cancer 17: 1–60

    Article  PubMed  CAS  Google Scholar 

  • Brennan JA, Boyle JO, Koch WM,Goodman SN, Hruban RH, EbyYJ,Couch MJ, Forastiere AA, Sidransky D (1995) Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N Engl J Med 332: 712–717

    Article  PubMed  CAS  Google Scholar 

  • Brownson RC, Novotny TE, Perry MC (1993) Cigarette smoking and adult leukemia:a meta-analysis. Arch Int Med 153: 469–475

    Article  CAS  Google Scholar 

  • Burch JD, Rohan TE, Howe GR, Risch HA, Hill GB, Steele R, Miller AB (1989) Risk of bladder cancer by source and type of tobacco exposure:a case control study. Int J Cancer 44: 622–628

    Article  PubMed  CAS  Google Scholar 

  • Calle EE, Miracle-McMahill HL, Thun MJ, Heath CW (1994) Cigarette smok- ing and risk of fatal breast cancer. Am J Epidemiol 139: 1001–1007

    PubMed  CAS  Google Scholar 

  • Denissenko MF, Pao A, Tang M, Pfeifer GP (1996) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science 274: 430–432

    Article  PubMed  CAS  Google Scholar 

  • Flanders WD, Rochman KJ (1982) Interaction of alcohol and tobacco in laryngeal cancer.Am J Epidemiol 115: 371–379

    CAS  Google Scholar 

  • Fontanini G,Vignati S, Bigini D, Merlo GR, Ribecchini A,Angeletti CA, Baso-lo F, Pingitore R, Bevilacqua G (1994) Human non-small cell lung cancer: p53 protein accumulation is an early event and persists during metastatic progression.] Pathol 174: 23–31

    Google Scholar 

  • Fontham ETH, Correa P, Reynolds P et al. (1994) Environmental tobacco smoke and lung cancer in nonsmoking women: a multicenter study. JAMA 271: 1752–1759

    Article  PubMed  CAS  Google Scholar 

  • Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.Cancer Res 54: 4855–4878

    CAS  Google Scholar 

  • Hartge P, Silverman D, Hoover R, Schairer C, Altman R, Austin D, Cantor K, Child M, Key K, Marrett LD (1987) Changing cigarette habits and bladder cancer risk: a case control study. J Nat Cancer Inst 78: 1119–1125

    PubMed  CAS  Google Scholar 

  • Hietanen E, Husgafvel-Pursiainen K, Vainio H (1997) Interaction between dose and susceptibility to environmental cancer: a short review. Environ Health Perspect 105 [Suppl 4]: 749–754

    PubMed  CAS  Google Scholar 

  • Holly EA, Petrakis NL, Friend NF, Sarles DL, Lee RE, Flander LB (1986) Muta-genic mucus in the cervix of smokers. J Nat Cancer Inst 76: 983–986

    PubMed  CAS  Google Scholar 

  • Horn-Ross PL, Ljung BM, Morrow M (1997) Environmental factors and the risk of salivary gland cancer. Epidemiology 8: 414–419

    Article  PubMed  CAS  Google Scholar 

  • Horwitz RI, Smaldone LF, Viscoli CM (1988) An ecogenetic hypothesis for lung cancer in women. Arch Int Med 148: 2609–2612

    Article  CAS  Google Scholar 

  • Hussain SP, Harris CC (1998) Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumor suppressor genes. Cancer Res 58: 4023–4037

    PubMed  CAS  Google Scholar 

  • Johnson B,Kelley M (1993) Overview of genetic and molecular events in the pathogenesis of lung cancer. Chest 103: 1–3

    Article  Google Scholar 

  • Kagan E, Brody AR (1996) Immunopathology of asbestos-related lung disease.ln: Kradin RL, Robinson BWS (eds) Immunopathology of lung disease. Butterworth-Heinemann, Boston, pp 421–443

    Google Scholar 

  • Kaufman JA, Burke Ai (1997) The etiology and pathogenesis of laryngeal carcinoma. Otolaryngol Clin North Am 30: 1–19

    Google Scholar 

  • Koutsky LA, Galloway DA, Holmes KK (1988) Epidemiology of genital human papillomavirus infection. Epidemiol Rev 10: 122–163

    PubMed  CAS  Google Scholar 

  • Müller K-M (1986) Lungenbefunde und Rauchgewohnheiten-Pathologische Anatomie. In: Geisler LS (Hrsg) Rauchen und Atemwege-Präventive und therapeutische Aspekte. Verlag für angewandte Wissenschaften, München, S 65–84

    Google Scholar 

  • Muller K-M (1994) Kehlkopfkarzinom-Pathologische Anatomie. In: Hauptverband der gewerblichen Berufsgenossenschaften (HVBG) (eds) Larynxkarzinom durch Asbest?-BK-Report 2/94. Hauptverband der gewerblichen Berufsgenossenschaften, Sankt Augustin, S 37–46

    Google Scholar 

  • Müller K-M, Krohn BR (1980) Smoking habits and their relationship to pre-cancerous lesions of the Iarynx.J Cancer Res Clin Oncol 96: 211–217

    Article  Google Scholar 

  • Müller K-M,Wiethege Th, Krismann M,Junker K (2002) Molekulare Pathologie bösartiger pulmonaler und pleuraler Tumoren, Teil. 1: Pulmonale Tumoren. In: Ruckpaul D,Ganten D (eds) Handbuch der molekularen Medizin, Bd. 10. Springer, Berlin Heidelberg New York Tokyo, S. 29–64

    Google Scholar 

  • Müller K-M, Wiethege Th, Tolnay E, Junker K (1997) Variable Biologie der Lungentumoren-Prognosefaktoren durch den Pathologen? Atemw Lungenkrkh 23: 302–307

    Google Scholar 

  • Newcomb PA, Storer BE, Marcus PM (1995) Cigarette smoking in relation to risk of large bowel cancer in women. Cancer Res 55: 4906–4909

    PubMed  CAS  Google Scholar 

  • Parkin DM, Pisani P, Lopez AD, Masuyer E (1994) At least one in seven cases of cancer is caused by smoking.Global estimates for 1985. Int J Cancer 59: 494–504

    Article  Google Scholar 

  • Pisani P, Parkin DM, Ferlay J (1993) Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer 55: 891–903

    Google Scholar 

  • Pryor WA (1997) Cigarette smoke radicals and the role of free radicals in chemical carcinogenicity. Environ. Health Perspect 105 [Suppl 4]: 875–882

    PubMed  CAS  Google Scholar 

  • Rakel RE, Blum A (1990) Nicotine addiction. In: Rakel RE (ed) Textbook of family practice.4th edn.WB Saunders, Philadelphia, pp 1612–23

    Google Scholar 

  • Randerath E, Randerath K (1993) Monitoring tobacco smoke-induced DNA damage by 32P-postlabelling.IARC Sci Publ 124: 305–314

    CAS  Google Scholar 

  • Redmond DE (1970) Tobacco and cancer:The first clinical report, 1761. N Engl J Med 282: 18–23

    Article  PubMed  Google Scholar 

  • Reynolds P, Fontham ETH (1995) Passive smoking and lung cancer. Ann Med 27: 633–640

    Article  PubMed  CAS  Google Scholar 

  • Rosell R, Li S, Skacel Z, Mate JL, Maestre J, Canela M, Tolosa E, Armengol P, Barnadas A, Ariza A (1993) Prognostic impact of mutated K-ras gene in surgically resected non- small cell lung cancer patients. Oncogene 8: 2407–2412

    PubMed  CAS  Google Scholar 

  • Ruggeri BA, Bauer B, Zhang SY, Kleinszanto AJP (1994) Murine squamous cell carcinoma cell lines produced by a complete carcinogenesis protocol with benzo[a]pyrene exhibit characteristic p53 mutations and the absence of H-ras and cyl 1/cyclin D1 abnormalities. Carcinogenesis 15: 1613–1619

    Article  PubMed  CAS  Google Scholar 

  • Rusch V, Klimstra D, Linkov I, Dmitrovsky E (1995) Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia, and coexpression precedes squamous cell carcinoma development. Cancer Res 55: 1365–1372

    PubMed  CAS  Google Scholar 

  • Sasson IM, Haley M, Hoffmann D, Wynder EL, Hellberg D, Nilsson S (1985) Cigarette smoking and neoplasia of the uterine cervix: Smoke constituents in cervical mucus. N Engl J Med 312: 315–316

    Google Scholar 

  • Schottenfeld D (1984) Epidemiology of cancer of the esophagus. Semin. Oncol. 1 1: 92–100

    Google Scholar 

  • Schottenfeld D, Gantt RC,Wynde EL (1974) The role of alcohol and tobacco in multiple primary cancers of the upper digestive system, larynx,and lung: A prospective study. Prey. Med. 3: 277–93

    Google Scholar 

  • Slebos RJ, Kibbelaar RE, Dalesio O, Kooistra A, Stam J, Meijer CJ, Wagenaar SS, Vanderschueren RG, van Zandwijk N, Mooi WJ (1990) K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N. EngI.J Med 323: 561–5

    Article  CAS  Google Scholar 

  • Soussi T (1996) The p53 tumour suppressor gene: a model for molecular epidemiology of human cancer. Mol. Med.Today 32–7

    Google Scholar 

  • Suzuki H, Takahashi T, Kuroishi T, Suyama M, Ariyoshi Y, Ueda R (1992) p53 mutations in non-small cell lung cancer in Japan:association between mutations and smoking. Cancer Res 52: 734–736

    Google Scholar 

  • Suzuki K, Nagai K, Yoshida J, Nishimura M,Takahashi K,YokoseT, Nishiwaki Y (1999) Conventional clinicopathologic prognostic factors in surgically resected nonsmall cell lung carcinoma. Cancer 86: 1976–84

    CAS  Google Scholar 

  • Thomas M (1997) Tumorassoziierte Prognoseparameter beim nicht-kleinzelligen Bronchialkarzinom. Pneumologie 51: 669–677

    PubMed  CAS  Google Scholar 

  • Tredaniel J, Boffetta P, Buiatti E, Saracci R, Hirsch A (1997) Tobacco smoking and gastric cancer: review and meta-analysis. Int J Cancer 72: 565–473

    Article  PubMed  CAS  Google Scholar 

  • Tseng JE, Rodriguez M, Ro J, Liu D, Hong WK, Mao L (1999) Gender differences in p53 mutational status in small cell lung cancer.Cancer Res 59: 5666–5970

    CAS  Google Scholar 

  • US Department of Health and Human Services (1982) The health consequences of smoking: Cancer: A report of the Surgeon General. Washington DC, US Department of Health and Human Services. Office on Smoking and Health 82–50179

    Google Scholar 

  • US Department of Health and Human Services. The health consequences of using smokeless tobacco: A report of the Advisory Committee to the Surgeon General. Washington DC, US Department of Health and Human Services, Public Health Service, NIH, (1986) 86–2874

    Google Scholar 

  • US Department of Health EaW. Smoking and health: A report of the Surgeon General.Washington DC, Public Health Service, Office of the Assistant Secretary for Health, Office on Smoking and Health, (1979) 79–50066

    Google Scholar 

  • WiethegeT, Junker K, Johnen G, Krismann M, Müller K-M (2000) Pathologie und Molekularbiologie bösartiger pulmonaler Tumoren. Pathologe 21: 404–423

    Article  Google Scholar 

  • Williams RR, Horn JW (1977) Association of cancer sites with tobacco and alcohol consumption and socioeconomic status of patients:Interview study from the Third National Cancer Survey. J. Nat Cancer Inst 58: 525–475

    PubMed  CAS  Google Scholar 

  • Wyser C, Bolliger CT (1997) Smoking-related disorders. In: Bolliger CT, Fagerström KO (eds) The tobacco epidemic. Karger, Basel, S. 78–106

    Chapter  Google Scholar 

  • Zang EA, Wynder EL (1996) Differences in lung cancer risk between men and women: examination of the evidence. J. Nat. Cancer Inst. 88: 183–192

    PubMed  CAS  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Müller, KM., Wiethege, T. (2004). Rauchen und Krebs. In: Die Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-06670-6_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-06670-6_11

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-06671-3

  • Online ISBN: 978-3-662-06670-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics